ゲノミクスにおけるAIの世界市場

世界のゲノミクスにおけるAIの市場規模は、2021年の4億9,860万米ドルから、予測期間中は47.3%のCAGRで推移し、2027年には48億米ドルを超える規模に成長すると予測されています。

地域別で見ると、北米地域は2021年の2億1,860万米ドルから、予測期間中は44.8%で推移し、2027年には19億米ドルを超える規模に成長すると予測されています。また、アジア太平洋地域は、2021年の1億2,030万米ドルから、50.5%で推移し、2027年には13億米ドルを超える規模に成長すると予測されています。

当レポートでは、世界のゲノミクスにおけるAIの市場を調査し、市場および技術の背景、新型コロナウイルス感染症 (COVID-19) およびその他の市場影響因子の分析、市場規模の推移・予測、各種区分・地域/主要国別の内訳、関連法規制、特許動向、競合環境、主要企業のプロファイルなどをまとめています。

目次

第1章 イントロダクション

第2章 サマリー・ハイライト

第3章 概要

• AI：イントロダクション
• ヘルスケアにおけるAI
• ヘルスケアの進化と移行におけるAI
• ゲノミクス：イントロダクション
• AIの分析
• ソフトウェア開発

第4章 COVID-19の影響

• COVID-19：市場への影響
• MedTechへの影響
• ヘルスケア関連製品の消費動向の変化

第5章 市場力学

• 市場促進要因
• 市場抑制要因・課題
• 市場機会

第6章 市場の内訳：提供内容別

• ソフトウェア
• 市場規模・予測
• サービス
• 市場規模・予測

第7章 市場の内訳：技術別

• 機械学習
• 市場規模・予測
• コンピュータビジョン
• 市場規模・予測

第8章 ゲノミクスにおけるAI：用途別

• 診断
• 市場規模・予測
• 創薬・開発
• 創薬のプロセス
• 創薬の歴史
• 創薬で使用される技術の分類
• 市場規模・予測
• その他
• 市場規模・予測

第9章 市場の内訳：地域別

• 地域別
• 北米
• 欧州
• アジア太平洋
• その他の地域

第10章 法規制・ファイナンス

• 規制の枠組み
• 米国糖尿病学会の糖尿病医療基準
• AIのためのATAガイドライン
• インドのAIガイドライン・戦略・標準

第11章 特許レビュー

第12章 競合情勢

第13章 企業プロファイル

• BENEVOLENTAI
• DATA4CURE INC.
• DEEP GENOMICS
• DNANEXUS INC.
• FDNA INC.
• GENOOX
• INTERNATIONAL BUSINESS MACHINES CORP.(IBM)
• LIFEBIT
• MICROSOFT CORP.
• NVIDIA
• SOPHIA GENETICS

List of Tables

• Summary Table : Global Market for AI in Genomics, by Region, Through 2027
• Table 1 : Cancer Statistics Across Major Asian Countries, by Cancer Site/Type, 2020
• Table 2 : Global Market for AI in Genomics, by Offering, Through 2027
• Table 3 : Global Market for AI in Genomics, by Technology, Through 2027
• Table 4 : Global Market for AI in Genomics, by Application, Through 2027
• Table 5 : History of Drug Discovery
• Table 6 : Global Market for AI in Genomics, by Region, Through 2027
• Table 7 : North American Market for AI in Genomics, by Offering, Through 2027
• Table 8 : North American Market for AI in Genomics, by Technology, Through 2027
• Table 9 : North American Market for AI in Genomics, by Application, Through 2027
• Table 10 : North American Market for AI in Genomics, by Country, Through 2027
• Table 11 : European Market for AI in Genomics, by Offering, Through 2027
• Table 12 : European Market for AI in Genomics, by Technology, Through 2027
• Table 13 : European Market for AI in Genomics, by Application, Through 2027
• Table 14 : European Market for AI in Genomics, by Country, Through 2027
• Table 15 : Asia-Pacific Market for AI in Genomics, by Offering, Through 2027
• Table 16 : Asia-Pacific Market for AI in Genomics, by Technology, Through 2027
• Table 17 : Asia-Pacific Market for AI in Genomics, by Application, Through 2027
• Table 18 : Asia-Pacific Market for AI in Genomics, by Country, Through 2027
• Table 19 : Number of New Cancer Cases in Japan in Both Sexes, 2020
• Table 20 : Rest of the World Market for AI in Genomics, by Offering, Through 2027
• Table 21 : Rest of the World Market for AI in Genomics, by Technology, Through 2027
• Table 22 : Rest of the World Market for AI in Genomics, by Application, Through 2027
• Table 23 : Regulations Pertaining AI Genomics in Select Countries
• Table 24 : Analysis of Patents Related to AI in Genomics
• Table 25 : Leading Market Players in the AI Genomics Market Ecosystem
• Table 26 : BenevolentAI: Product Portfolio
• Table 27 : Data4Cure: Product Portfolio
• Table 28 : Deep Genomics: Product Portfolio
• Table 29 : DNAnexus: Product Portfolio
• Table 30 : FDNA Inc.: Product Portfolio
• Table 31 : Genoox: Product Portfolio
• Table 32 : IBM Corp.: Company Financials, 2020 and 2021
• Table 33 : IBM: Product Portfolio
• Table 34 : IBM Corp.: Company Strategic Developments, 2017-2019
• Table 35 : Lifebit: Product Portfolio
• Table 36 : Microsoft Corp.: Financials, 2019-2021
• Table 37 : Microsoft Corp.: Product Portfolio
• Table 38 : Microsoft Corp.: Strategies and Developments
• Table 39 : Nvidia: Company Financials, 2019 and 2020
• Table 40 : Nvidia: Product Portfolio
• Table 41 : SOPHiA GENETICS: Product Portfolio

List of Figures

• Summary Figure A : Global AI In Genomics Market, by Region, 2020-2027
• Summary Figure B : Global Market Shares of AI in Genomics, by Region, 2021
• Figure 1 : Global Funding in Health-Tech Companies
• Figure 2 : Global Projections of Deaths from the Top Three Chronic Diseases, 2005-2030
• Figure 3 : Increased Incidence of Cancer, 2012 and 2030
• Figure 4 : Global Distribution of Deaths from Chronic Diseases, 2019
• Figure 5 : Funding for Disease Research, 2014-2018
• Figure 6 : Rising Trends in Healthcare Spending, by Institution, 2015-2035
• Figure 7 : Global Market Shares of AI in Genomics, by Offering, 2021
• Figure 8 : Global Market for AI in Genomics, by Offering, 2020-2027
• Figure 9 : Global Market for Software in Software in an AI Systems, 2020-2027
• Figure 10 : Global Market for AI Services, 2020-2027
• Figure 11 : Global Market Shares of AI in Genomics, by Technology, 2021
• Figure 12 : Global Market for AI in Genomics, by Technology, 2020-2027
• Figure 13 : Global Market for Machine Learning, 2020-2027
• Figure 14 : Global Market for Computer Vision, 2020-2027
• Figure 15 : Global Market Shares of AI in Genomics, by Application, 2021
• Figure 16 : Global Market for AI in Genomics, by Application, 2020-2027
• Figure 17 : Global Market for AI in Diagnostics, 2020-2027
• Figure 18 : Process of Drug Discovery
• Figure 19 : Global Market for AI in Drug Discovery and Development, 2020-2027
• Figure 20 : Global Market for Other Applications of AI in Genomics, 2020-2027
• Figure 21 : Global Market Shares of AI in Genomics, by Region, 2021
• Figure 22 : North American Market Shares of AI in Genomics, by Offering, 2021
• Figure 23 : North American Market Shares of AI in Genomics, by Technology, 2021
• Figure 24 : North American Market Shares of AI in Genomics, by Application, 2021
• Figure 25 : North American Market Shares of AI in Genomics, by Country, 2021
• Figure 26 : U.S. Market for AI in Genomics, 2020-2027
• Figure 27 : Canadian Market for AI in Genomics, 2020-2027
• Figure 28 : European Market Shares of AI in Genomics, by Offering, 2021
• Figure 29 : European AI Genomics Market Shares, by Technology, 2021
• Figure 30 : European Market Shares of AI in Genomics, by Application, 2021
• Figure 31 : European Market Shares of AI in Genomics, by Country, 2021
• Figure 32 : Geriatric Population in Germany, 2000-2030
• Figure 33 : German Market for AI in Genomics, 2020-2027
• Figure 34 : U.K. Market for AI in Genomics, 2020-2027
• Figure 35 : French Market for AI in Genomics, 2020-2027
• Figure 36 : Italian Market for AI in Genomics, 2020-2027
• Figure 37 : Spanish Market for AI in Genomics, 2020-2027
• Figure 38 : Rest of Europe Market for AI in Genomics, 2020-2027
• Figure 39 : Asia-Pacific Market Shares of AI in Genomics, by Offering, 2021
• Figure 40 : Asia-Pacific Market Shares of AI in Genomics, by Technology, 2021
• Figure 41 : Asia-Pacific Market Shares of AI in Genomics, by Application, 2021
• Figure 42 : Asia-Pacific Market Shares of AI in Genomics, by Country, 2021
• Figure 43 : New Cancer Cases in China, 2020
• Figure 44 : Distribution of New Cancer Cases in China, 2020
• Figure 45 : Chinese Market for AI in Genomics, 2020-2027
• Figure 46 : Japanese Market for AI in Genomics, 2020-2027
• Figure 47 : Indian Market for AI in Genomics, 2020-2027
• Figure 48 : Rest of Asia-Pacific Market for AI in Genomics, 2020-2027
• Figure 49 : New Cancer Cases in Africa, 2020
• Figure 50 : Rest of the World Market Shares of AI in Genomics, by Offering, 2021
• Figure 51 : Rest of the World Market Shares of AI in Genomics, by Technology, 2021
• Figure 52 : Rest of the World Market Shares of AI in Genomics, by Application, 2021
• Figure 53 : Microsoft Corp.: Revenue Share, by Region/Country, 2021

Highlights:

The global market for AI in genomics reached $498.6 million in 2021 and should reach more than $4.8 billion in 2027, with a compound annual growth rate (CAGR) of 47.3% during the forecast period of 2021-2027.

North American market reached $218.6 million in 2021 and should reach more than $1.9 billion in 2027 with a (CAGR) of 44.8% during the forecast period of 2021-2027.

Asia-Pacific market reached $120.3 million in 2021 and should reach more than $1.3 billion in 2027 with a (CAGR) of 50.5% during the forecast period of 2021-2027.

Report Scope:

This report highlights the current and future market potential for AI genomics and provides a detailed analysis of the competitive environment, regulatory scenario, drivers, restraints, opportunities, and trends in the market. The report also covers market projections through 2027 as well as key market players. BCC Research analyzes each technology in detail, determines major players and current market

status, and presents forecasts of growth over the next five years. Scientific challenges and advances, including the latest trends, are emphasized. Government regulations, major collaborations, recent patents, and factors affecting the industry from a global perspective are examined.

Key AI in genomics technologies and products are analyzed to determine present and future market status, and growth is forecast from 2022 to 2027. An in-depth discussion of strategic alliances, industry structures, competitive dynamics, patents, and market driving forces are also provided.

Report Includes:

• 23 data tables and 19 additional tables
• An overview of the global market for artificial intelligence (AI) in genomics applications
• Analyses of the global market trends, with revenue data from 2020-2021, estimates for 2022, and projections of compound annual growth rates (CAGRs) through 2027
• Highlights of the current and future market potential for the AI genomics industry with an emphasis on new products and technologies, and areas of focus to forecast this market into various segments and sub-segments
• Evaluation and forecast the global AI genomics market size, and corresponding market share analysis by technology, offerings, application, and geographic region
• Technology assessment of the key drivers, restraints and opportunities that will shape the market for AI in genomics over the forecast period (2021 to 2027)
• In-depth information on major technology issues and challenges, government regulations, breakthrough innovations, collaborations and developments, and costs and benefits of AI applications in the genomics industry
• Review of recent industry trends, R&D activities, competitive landscape featuring key market participants, and COVID-19 implications within the AI genomics market ecosystem
• Company profiles of major players, including BenevolentAI, Data4Cure Inc., Deep Genomics, IBM Corp., and Microsoft Corp.

Table of Contents

Chapter 1 Introduction

• Study Goals and Objectives
• Reasons for Doing the Study
• Intended Audience
• Scope and Format
• Methodology
• Information Sources
• Geographical Breakdown
• Analyst's Credentials
• BCC Custom Research
• Related BCC Research Reports

Chapter 2 Summary and Highlights

Chapter 3 Overview

• Introduction to Artificial Intelligence
• Understanding Artificial Intelligence in Healthcare
• Artificial Intelligence in Healthcare Evolution and Transition
• Introduction to Genomics
• Artificial Intelligence (AI) Analysis
• Software Development

Chapter 4 Impact of the COVID-19 Pandemic

• Introduction
• Impact of COVID-19 on the Market
• Impact on MedTech
• Changes in Consumption Trends for Health-Related Products

Chapter 5 Market Dynamics

• Market Drivers
• Investment in AI Health Sector
• Increasing Strategic Moves by Market Players and Governments
• Increasing Incidences of Chronic Disease
• Demand for Personalized Medicine
• Increasing Research and Development Budget
• Restraints and Challenges
• Reluctance Among Medical Practitioners to Adopt AI-Based Technologies
• Ambiguous Regulatory Guidelines for Medical Software
• Challenge to Maintain Data Security
• Opportunities
• Untapped Potential in Emerging Markets

Chapter 6 Market Breakdown by Offering

• Software
• Market Size and Forecast
• Services
• Market Size and Forecast

Chapter 7 Market Breakdown by Technology

• Machine Learning
• Market Size and Forecast
• Computer Vision
• Market Size and Forecast

Chapter 8 AI in Genomics by Application

• Diagnostics
• Market Size and Forecast
• Drug Discovery and Development
• Process of Drug Discovery
• History of Drug Discovery
• Classification of Techniques Used in Drug Discovery
• Market Size and Forecast
• Others
• Market Size and Forecast

Chapter 9 Market Breakdown by Region

• Global Market for AI in Genomics by Region
• North America
• U.S.
• Canada
• Europe
• Germany
• U.K.
• France
• Italy
• Spain
• Rest of Europe
• Asia-Pacific
• China
• Japan
• India
• Rest of Asia-Pacific
• Rest of the World

Chapter 10 Regulations and Finance

• Regulatory Framework
• American Diabetes Association's Standards of Medical Care in Diabetes
• ATA Guidelines for Artificial Intelligence
• Indian AI Guidelines, Strategy, and Standards

Chapter 11 Patent Review

Chapter 12 Competitive Landscape

• Overview
• Recent Developments

Chapter 13 Company Profiles

• BENEVOLENTAI
• DATA4CURE INC.
• DEEP GENOMICS
• DNANEXUS INC.
• FDNA INC.
• GENOOX
• INTERNATIONAL BUSINESS MACHINES CORP. (IBM)
• LIFEBIT
• MICROSOFT CORP.
• NVIDIA
• SOPHIA GENETICS